Four compounds define the looksmaxxing corner of peptide pharmacology. GHK-Cu drives collagen synthesis and skin tightening at the injection site. Melanotan-II triggers melanogenesis — a real, UV-activated tan — without needing hours of sun to initiate it. KLOW is the pre-blended shortcut: GHK-Cu plus three other peptides in a single vial. KPV handles the anti-inflammatory layer — gut repair, microbial balance, and systemic inflammation control. None of these touch the HPTA. No testosterone suppression, no PCT, no hormonal cascade to manage.
This post covers how each one works, practical dosing, and how they fit together.
The lineup
- GHK-Cu — bioidentical copper-binding tripeptide; stimulates dermal collagen synthesis at the injection site; suitable for continuous use
- Melanotan-II — synthetic alpha-MSH analog; activates melanocortin receptors to trigger melanin production without UV required to initiate it; also suppresses appetite and raises libido
- KLOW — pre-blended vial of GHK-Cu + TB-500 + BPC-157 + KPV; one vial handles collagen synthesis, systemic healing, and anti-inflammatory coverage simultaneously
- KPV — tripeptide derived from the C-terminal sequence of alpha-MSH; anti-inflammatory, antimicrobial, supports gut microbiome rebalancing; included in KLOW
GHK-Cu
GHK-Cu — glycyl-l-histidyl-l-lysine copper — is a copper-binding peptide the body produces naturally. Because it’s bioidentical, it can be run for months or indefinitely, unlike synthetic healing peptides such as BPC-157 and TB-500 that are typically cycled six to eight weeks.
The mechanism is collagen synthesis, and the effect is primarily local — skin thickening occurs at the injection site, not systemically. Five milligrams injected directly into an injured shoulder daily has shown significant improvement within three days in anecdotal use. The same site-specific principle has been used for deliberate site enhancement: injecting into the tricep over months produces localized collagen density and visible shaping, at the cost of significant post-injection pain.
For anti-aging goals — skin tightening, gray hair (mechanistically plausible, not confirmed in clinical literature), connective tissue density — ramp slowly: 1 mg/day for the first two weeks, up to 2 mg, then 5 mg. The accepted range sits at 2–5 mg/day.
Post-injection pain is the dominant side effect. It lasts a few hours and is a property of injecting a trace mineral — not inflammation. Subcutaneous into fatty tissue is less painful than intramuscular; start there.
GHK-Cu is 18.7% copper by molecular weight. You would need to inject roughly 32–33 mg per day to approach copper toxicity in an average adult — far above practical doses. Still, supplement with 25 mg zinc picolinate throughout the run; copper and zinc compete for the same binding proteins. Women using copper IUDs carry additional copper load and should account for it.
Melanotan-II
Melanotan-II is a synthetic analog of alpha-melanocyte-stimulating hormone. It activates melanocortin receptors (MC1R–MC4R), triggering melanogenesis without requiring UV exposure to initiate the process. UV still develops the color — MT-2 primes the machinery so the response is faster and deeper on less sun. MC3R/MC4R activation also produces appetite suppression, libido increase, and mood-elevating effects. Spontaneous erections at higher doses are a known MC4R effect; worth knowing before the first injection.
The tanning protocol: loading phase at 100–250 mcg subcutaneously before bed daily, with UV exposure on the same days, until target tone is reached (typically two to six weeks). Maintenance is once per week. Without maintenance, the tan fades over six to nine months.
Nausea and flushing are the dominant side effects in the first one to two weeks. Standard mitigation: inject before bed, take 25–50 mg diphenhydramine (Benadryl) 30–45 minutes before to blunt the flushing response. Nausea typically resolves within the first two weeks as the body adapts. Freckles and pre-existing moles darken; monitor moles you already have. White spots that won’t tan are typically Tinea Versicolor, a common fungal skin condition unrelated to MT-2 — a standard antifungal treatment handles it; stopping MT-2 is not required.
MT-2 is not on the WADA prohibited list, is not hormonal, requires no PCT, and is appropriate for female users. One note for enhanced users: at tanning doses of 0.5–1 mg/day, hematocrit does not meaningfully change in drug-free individuals. In users already on anabolic steroids, particularly trenbolone, hematocrit can rise due to melanocortin receptor overlap. Monitor if running both.
KLOW — the blend
KLOW combines four peptides — GHK-Cu, TB-500, BPC-157, and KPV — into a single vial. Instead of managing four separate reconstitution calculations and dosing schedules, one vial covers the full stack.
GHK-Cu is the primary active component and the basis for dosing. The 80 mg vial with 2 mL BAC water gives 40 mg/mL — slightly different concentration than standalone GHK-Cu; use the calculator for exact draw. Dosing mirrors the GHK-Cu ramp: 1 mg/day to start, 2–5 mg as the working range. BPC-157 adds GH receptor upregulation in tendon fibroblasts; TB-500 adds systemic healing support; KPV adds anti-inflammatory coverage. For someone who wants GHK-Cu for skin plus needs the healing stack — recovering from injury, managing chronic inflammation — KLOW covers both without separate sourcing decisions.
For skin and anti-aging: run three to six months minimum; continuous use is fine. For acute injury: treat as a standard BPC-157/TB-500 course, six to eight weeks, then reassess. Post-injection pain and zinc supplementation (25 mg zinc picolinate) apply as with standalone GHK-Cu.
KPV
KPV is a tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone. It retains the parent peptide’s anti-inflammatory and antimicrobial activity with none of the melanogenic effects. Two main use cases:
Gut healing: KPV has antimicrobial and antifungal properties, addresses candida overgrowth, supports butyrate production, and preserves beneficial gut flora. Unlike most peptides it is orally bioavailable — oral KPV at 500 mcg/day alongside oral BPC-157 and larazotide is a standard gut healing stack.
Systemic anti-inflammation: as part of an injury or skin protocol, KPV controls the inflammatory environment that slows collagen deposition and tissue repair. This is its role in KLOW.
Injection-site redness is more visible with KPV than with other healing peptides; rotate sites. KPV landed on the FDA Section 503a restricted list in October 2023 alongside BPC-157. Elevated CRP (above 3) is the clearest indicator that KPV’s mechanism is most relevant to a protocol.
How they combine
The core pairing is MT-2 plus GHK-Cu or KLOW, because the two sides address different biology. MT-2 drives melanin density and UV-accelerated pigmentation. GHK-Cu or KLOW drives dermal collagen synthesis and skin quality. They do not compete; they layer.
KLOW versus components separately: KLOW locks in a fixed ratio. If you need to cycle BPC-157 independently while keeping GHK-Cu running continuously, or dial in a higher GHK-Cu dose than the blend allows, separate vials give you that control. For most users starting out, KLOW is the simpler call.
KPV is already in KLOW. Standalone KPV makes most sense when gut healing is the primary goal — oral KPV plus oral BPC-157 for the gut while running injectable GHK-Cu for skin.
The stack picks
- Tan only: Melanotan-II at 100–250 mcg before bed, Benadryl 25–50 mg pre-injection, UV exposure on dosing days. Load daily until target tone achieved; maintain with once-weekly doses.
- Skin and collagen only (no tan goal): GHK-Cu at 1 mg/day to start, ramp to 2–5 mg over 4–6 weeks; or KLOW at the same ramp for the all-in-one approach. Zinc supplementation required throughout.
- Full looksmaxxing stack — simplest: Melanotan-II loading protocol plus KLOW daily. MT-2 handles pigment; KLOW handles collagen, healing, and inflammation in one vial.
- Full stack with individual titration control: Melanotan-II plus standalone GHK-Cu at your preferred dose, with KPV added orally if gut healing or elevated CRP is also a concern.
- Gut healing alongside the skin stack: Oral KPV 500 mcg/day plus oral BPC-157, combined with injectable GHK-Cu or KLOW for the skin side. Covers both targets without overlap conflicts.
The bottom line
These four peptides occupy different mechanisms with no meaningful overlap: melanin (MT-2), local collagen synthesis (GHK-Cu), the all-in-one healing and collagen blend (KLOW), and anti-inflammatory coverage (KPV, already included in KLOW). None suppress the HPTA or require post-cycle management.
The natural starting point is MT-2 plus KLOW — one gives you the tan, the other gives you skin quality — and nothing more complex than that is needed for the core looksmaxxing goal. For reconstitution math on any of these, use the KLOW calculator. For dosing ramp schedules, timing protocols, and the full skin and collagen stack guidance, see the free Peptide Guide.